Takeda Pharmaceutical (TAK) to Release Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAK) will issue its quarterly earnings data before the market opens on Thursday, May 9th. Individual interested in registering for the company’s earnings conference call can do so using this link.

Takeda Pharmaceutical Trading Down 0.6 %

Shares of NYSE:TAK opened at $13.28 on Wednesday. The stock has a market capitalization of $42.03 billion, a price-to-earnings ratio of 20.12, a PEG ratio of 3.05 and a beta of 0.56. Takeda Pharmaceutical has a 1-year low of $13.01 and a 1-year high of $17.11. The company has a 50 day moving average price of $13.85 and a 200 day moving average price of $14.10. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.55 and a current ratio of 1.06.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.